Nektar Therapeutics Stock Split Ratio
Nektar Therapeutics (NKTR) reported Stock Split Ratio of 7.00% for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-05-08
- Nektar Therapeutics stockholders' equity note, stock split, conversion ratio for the quarter ending 2026-03-31 was 7.00%, a 0.00% change year-over-year.
- Nektar Therapeutics stockholders' equity note, stock split, conversion ratio for the quarter ending 2025-03-31 was 7.00%.
- Nektar Therapeutics stockholders' equity note, stock split, conversion ratio for the quarter ending 2024-09-30 was 7.00%.
- Nektar Therapeutics stockholders' equity note, stock split, conversion ratio for the quarter ending 2024-06-30 was 7.00%.
- Nektar Therapeutics stockholders' equity note, stock split, conversion ratio for fiscal 2024 was 7.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 6 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | 7.00% 10-Q · filed 2026-05-08 | ||||
| 2025-03-31 | 7.00% 10-Q · filed 2026-05-08 | ||||
| 2024-12-31 | 7.00% 10-K · filed 2026-03-13 | 6.67% 10-Q · filed 2025-08-08 | |||
| 2024-09-30 | 7.00% 10-Q · filed 2025-11-07 | 7.00% 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | 7.00% 10-Q · filed 2025-08-08 | 7.00% 10-Q · filed 2025-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |